Last CNY42.08 CNY
Change Today -2.26 / -5.10%
Volume 10.4M
002038 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

beijing sl pharmaceutical -a (002038) Snapshot

Open
CNY43.55
Previous Close
CNY44.34
Day High
CNY43.63
Day Low
CNY42.02
52 Week High
01/9/14 - CNY58.83
52 Week Low
04/2/14 - CNY37.60
Market Cap
19.2B
Average Volume 10 Days
7.5M
EPS TTM
CNY1.46
Shares Outstanding
456.8M
EX-Date
07/4/14
P/E TM
28.8x
Dividend
CNY0.20
Dividend Yield
0.48%
Current Stock Chart for BEIJING SL PHARMACEUTICAL -A (002038)

Related News

No related news articles were found.

beijing sl pharmaceutical -a (002038) Related Businessweek News

No Related Businessweek News Found

beijing sl pharmaceutical -a (002038) Details

Beijing SL Pharmaceutical Co., Ltd., a biotechnology-pharmaceutical company, develops and markets gene engineering drugs for human health. Its principal products include Li Sheng Su, a recombinant human granulocyte colony-stimulating factor for injection; Mai Ge Er, a recombinant human interleukin-11 for injection; and Xin Ji Er, a recombinant human 125Ala interleukin-2 for injection. The company also offers Fu Ji Fu, a lyophilized recombinant human basic fibroblast growth factor for external use. In addition, it provides products for oncology, organ transplantation, cardiovascular, wound management, liver diseases, as well as APIs. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. The company was founded in 1994 and is based in Beijing, the People’s Republic of China.

Founded in 1994

beijing sl pharmaceutical -a (002038) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing sl pharmaceutical -a (002038) Key Developments

Beijing SL Pharmaceutical Co., Ltd. to Report Q3, 2014 Results on Oct 24, 2014

Beijing SL Pharmaceutical Co., Ltd. announced that they will report Q3, 2014 results on Oct 24, 2014

Beijing SL Pharmaceutical Co., Ltd. to Report First Half, 2014 Results on Aug 20, 2014

Beijing SL Pharmaceutical Co., Ltd. announced that they will report first half, 2014 results on Aug 20, 2014

Beijing SL Pharmaceutical Co., Ltd. Declares Cash Dividend for the Year 2013

Beijing SL Pharmaceutical Co., Ltd. declared cash dividend per 10 shares (tax included) of CNY 2.00000000 for the year 2013, at the annual general meeting held on 16 May 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002038:CH CNY42.08 CNY -2.26

002038 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002038.
View Industry Companies
 

Industry Analysis

002038

Industry Average

Valuation 002038 Industry Range
Price/Earnings 30.3x
Price/Sales 16.2x
Price/Book 6.7x
Price/Cash Flow 30.3x
TEV/Sales 15.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING SL PHARMACEUTICAL -A, please visit www.slpharm.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.